In Gastroesophageal Cancers, Better Prevention and Treatments Needed
Since chemotherapy can offer only a limited amount of help in fighting gastroesophageal cancers, a growing emphasis on prevention — as well as on the development of immunotherapies — will be extremely important.
Medical Illustration: Targeting HER2 in Gastric Cancer
For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
Cholangiocarcinoma Research is Expanding, But Many Questions Are Still Unanswered
Research into treatments for cholangiocarcinoma is branching out, but there are still more questions than answers.
The Next Frontier: The Promise of Immunotherapy in Gastrointestinal Cancers
In the oncology world, gastrointestinal cancers may be the next in line to realize the promise of immunotherapy.
Gastrointestinal Stromal Tumors Already Proving to Be Treatable With Targeted Therapies
Identified only a decade-and-a-half ago, GIST is already treatable with several targeted therapies, and scientists are researching more.
Searching on all Fronts: Changing the Outlook for Those With Pancreatic Cancer
Scientists are investigating a host of new treatment types that may change the outlook for those with pancreatic cancer.
Right in the Gut: New Clues About Preventing and Treating Gastric Cancer
Diagnoses in younger people and two causative infections are providing clues about how to better prevent and treat gastric cancer.
An Insight Into Gastric Cancers and Life Without a Stomach
The decision to remove one's stomach may be difficult, but it can also be life-saving.
Changing Lives With Immunotherapy
When it comes to gastrointestinal (GI) cancers, there’s quite a disparity in the gains that research is bringing us.
2 Clarke Drive Cranbury, NJ 08512